D. Cohen

2.2k total citations
48 papers, 1.4k citations indexed

About

D. Cohen is a scholar working on Genetics, General Health Professions and Immunology. According to data from OpenAlex, D. Cohen has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 9 papers in General Health Professions and 9 papers in Immunology. Recurrent topics in D. Cohen's work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (7 papers) and Health Services Management and Policy (5 papers). D. Cohen is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (7 papers) and Health Services Management and Policy (5 papers). D. Cohen collaborates with scholars based in United Kingdom, United States and Switzerland. D. Cohen's co-authors include Walter M. Gregory, Peter Hillmen, Lindsay Mitchell, Matthew Cullen, Stephen J. Richards, Louise Arnold, Richard Kelly, Anita Hill, Margaret A. Knowles and Dewi Astuti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

D. Cohen

44 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Cohen United Kingdom 13 438 373 339 277 264 48 1.4k
Stacy P. Ardoin United States 23 448 1.0× 234 0.6× 316 0.9× 63 0.2× 70 0.3× 86 1.5k
Michael Reusch Germany 21 280 0.6× 96 0.3× 707 2.1× 262 0.9× 62 0.2× 79 1.6k
Grace S. Park United States 19 409 0.9× 138 0.4× 221 0.7× 145 0.5× 112 0.4× 31 1.4k
Johanneke E.A. Portielje Netherlands 33 291 0.7× 236 0.6× 389 1.1× 101 0.4× 571 2.2× 144 3.4k
Jeanna Welborn United States 17 107 0.2× 178 0.5× 395 1.2× 343 1.2× 110 0.4× 35 1.3k
Jukka Rajantie Finland 27 283 0.6× 350 0.9× 670 2.0× 130 0.5× 537 2.0× 83 2.0k
Maria Dall’Era United States 29 1.5k 3.5× 150 0.4× 176 0.5× 141 0.5× 89 0.3× 99 3.0k
Alexa Meara United States 15 351 0.8× 151 0.4× 56 0.2× 86 0.3× 235 0.9× 49 1.2k
Alexander Gaiger Austria 32 438 1.0× 957 2.6× 872 2.6× 764 2.8× 246 0.9× 70 2.8k
Shibao Feng United States 20 55 0.1× 475 1.3× 326 1.0× 158 0.6× 259 1.0× 52 1.9k

Countries citing papers authored by D. Cohen

Since Specialization
Citations

This map shows the geographic impact of D. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Cohen more than expected).

Fields of papers citing papers by D. Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Cohen. The network helps show where D. Cohen may publish in the future.

Co-authorship network of co-authors of D. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of D. Cohen. A scholar is included among the top collaborators of D. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Cohen. D. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steeghs, Elisabeth M. P., C. J. Timmer, Jasper N. Smit, et al.. (2025). Liquid biopsy in BALF is now suitable for clinical practice in patients with suspected NSCLC. Lung Cancer. 209. 108771–108771.
2.
3.
Cohen, D.. (2015). GPs are told to treat with scepticism advice on anti-flu drugs from Public Health England. BMJ. 350(jan15 6). h258–h258. 3 indexed citations
4.
Cohen, D. & Helen Macdonald. (2015). Researchers say they will send unpublished alteplase data to UK drug regulator on request. BMJ. 350(jan09 6). h119–h119. 1 indexed citations
5.
Cohen, D., et al.. (2015). Doctors’ health: obstacles and enablers to returning to work. Occupational Medicine. 65(6). 459–465. 5 indexed citations
6.
Cohen, D., Susan Todd, Walter M. Gregory, & Julia Brown. (2015). Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice. Trials. 16(1). 179–179. 19 indexed citations
7.
Cohen, D.. (2015). BMA tells GPs to follow own judgment in prescribing antiflu drugs. BMJ. 350(jan20 35). h365–h365.
8.
Cohen, D.. (2014). Roche and Novartis colluded over wet AMD drugs, says Italian regulator. BMJ. 348(mar07 8). g2006–g2006. 7 indexed citations
9.
Cohen, D.. (2013). FDA official: "clinical trial system is broken". BMJ. 347(dec05 3). f6980–f6980. 10 indexed citations
10.
Butler, Christopher, Sharon Simpson, Kerenza Hood, et al.. (2013). Training practitioners to deliver opportunistic multiple behaviour change counselling in primary care: a cluster randomised trial. BMJ. 346(mar19 3). f1191–f1191. 99 indexed citations
11.
Hill, Anita, Richard J. Kelly, Austin Kulasekararaj, et al.. (2012). Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Report of All 153 Patients Treated in the UK. Blood. 120(21). 3472–3472. 13 indexed citations
12.
Kelly, Richard, Anita Hill, Louise Arnold, et al.. (2011). Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood. 117(25). 6786–6792. 347 indexed citations
13.
Hillmen, Peter, D. Cohen, Kim Cocks, et al.. (2011). A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia. British Journal of Haematology. 152(5). 570–578. 32 indexed citations
14.
Hudson, Shawna V., Karissa A. Hahn, D. Cohen, et al.. (2010). Features of the Chronic Care Model (CCM) Associated with Behavioral Counseling and Diabetes Care in Community Primary Care. The Journal of the American Board of Family Medicine. 23(3). 295–305. 33 indexed citations
15.
Belostotsky, Vladimir, Jo Adaway, Brian Keevil, D. Cohen, & Nicholas J.A. Webb. (2010). Measurement of saliva tacrolimus levels in pediatric renal transplant recipients. Pediatric Nephrology. 26(1). 133–138. 11 indexed citations
16.
Cohen, D. & Paul Carter. (2010). How small changes led to big profits for insulin manufacturers. BMJ. 341(dec15 1). c7139–c7139. 10 indexed citations
17.
Craven, Rachel A., D. Cohen, Claire Taylor, et al.. (2009). Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma. Clinical Cancer Research. 15(24). 7582–7592. 137 indexed citations
18.
Cocks, Kim, D. Cohen, Finn Wislöff, et al.. (2007). An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. European Journal of Cancer. 43(11). 1670–1678. 177 indexed citations
19.
Banks, Rosamonde E., Prasanna Tirukonda, Claire Taylor, et al.. (2006). Genetic and Epigenetic Analysis of von Hippel-Lindau ( VHL ) Gene Alterations and Relationship with Clinical Variables in Sporadic Renal Cancer. Cancer Research. 66(4). 2000–2011. 214 indexed citations
20.
Robling, Michael, Kerenza Hood, Ian Russell, et al.. (2002). The development of a new site-specific measure of quality of life for breast problems: The Cardiff breast scales. Quality of Life Research. 11(4). 339–348. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stacy P. Ardoin Breakdown of academic impact, for papers by Michael Reusch Breakdown of academic impact, for papers by Grace S. Park Breakdown of academic impact, for papers by Johanneke E.A. Portielje Breakdown of academic impact, for papers by Jeanna Welborn Breakdown of academic impact, for papers by Jukka Rajantie Breakdown of academic impact, for papers by Maria Dall’Era Breakdown of academic impact, for papers by Alexa Meara Breakdown of academic impact, for papers by Alexander Gaiger Breakdown of academic impact, for papers by Shibao Feng
Rankless by CCL
2026